Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination - PubMed (original) (raw)
Clinical Trial
. 2002 Jun 1;185(11):1657-9.
doi: 10.1086/340517. Epub 2002 May 17.
Affiliations
- PMID: 12023773
- DOI: 10.1086/340517
Clinical Trial
Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination
Francis A Ennis et al. J Infect Dis. 2002.
Abstract
This study measured the ability of a standard smallpox vaccine, given by scarification (by bifurcated needle), to induce primary human vaccinia virus-specific cytotoxic and interferon (IFN)-gamma-producing T lymphocyte responses. Because protection against smallpox may be mediated in part by T cell memory responses induced by vaccination, an analysis of the induction of primary human cytotoxic T lymphocytes (CTL) and IFN-gamma-producing T cell responses was performed. Although smallpox is no longer an epidemic threat under natural conditions, vaccination is still recommended for persons working with vaccinia viruses in the laboratory and for those who may be at risk from the potential use of smallpox virus as a bioterrorism agent. The results demonstrate that smallpox vaccine given by bifurcated needle induces strong vaccinia virus-specific CD8(+) CTL and IFN-gamma-producing T cell responses and provide baseline information useful for planning the immunologic assessment of future smallpox vaccines.
Similar articles
- Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.
Kennedy JS, Frey SE, Yan L, Rothman AL, Cruz J, Newman FK, Orphin L, Belshe RB, Ennis FA. Kennedy JS, et al. J Infect Dis. 2004 Oct 1;190(7):1286-94. doi: 10.1086/423848. Epub 2004 Aug 30. J Infect Dis. 2004. PMID: 15346340 Clinical Trial. - Real time PCR for the assessment of CD8+ T cellular immune response after prophylactic vaccinia vaccination.
Trojan A, Rajeswaran R, Montemurro M, Mütsch M, Steffen R. Trojan A, et al. J Clin Virol. 2007 Sep;40(1):80-3. doi: 10.1016/j.jcv.2007.04.022. Epub 2007 Jul 20. J Clin Virol. 2007. PMID: 17644471 - The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.
Kim SH, Yeo SG, Park KH, Bang JW, Kim HB, Kim NJ, Jee Y, Cho H, Oh MD, Choe KW. Kim SH, et al. Clin Microbiol Infect. 2007 Jan;13(1):91-3. doi: 10.1111/j.1469-0691.2006.01576.x. Clin Microbiol Infect. 2007. PMID: 17184294 - Monitoring of human immunological responses to vaccinia virus.
Harrop R, Ryan MG, Golding H, Redchenko I, Carroll MW. Harrop R, et al. Methods Mol Biol. 2004;269:243-66. doi: 10.1385/1-59259-789-0:243. Methods Mol Biol. 2004. PMID: 15114020 Review. - [Novel vaccines against M. tuberculosis].
Okada M. Okada M. Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.
Cited by
- Characterization of the Monkeypox Virus [MPX]-Specific Immune Response in MPX-Cured Individuals Using Whole Blood to Monitor Memory Response.
Petruccioli E, Sbarra S, Vita S, Salmi A, Cuzzi G, De Marco P, Matusali G, Navarra A, Pierelli L, Grifoni A, Sette A, Maggi F, Nicastri E, Goletti D. Petruccioli E, et al. Vaccines (Basel). 2024 Aug 26;12(9):964. doi: 10.3390/vaccines12090964. Vaccines (Basel). 2024. PMID: 39339995 Free PMC article. - Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine.
Greenberg RN, Schmidt D, Reichhardt D, Roesch S, Vidojkovic S, Maclennan J, Chen LM, Gruenert R, Kreusel C, Weidenthaler H, Meyer TPH, Chaplin PJ. Greenberg RN, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2384189. doi: 10.1080/21645515.2024.2384189. Epub 2024 Aug 22. Hum Vaccin Immunother. 2024. PMID: 39171509 Free PMC article. Clinical Trial. - Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination.
Matusali G, Petruccioli E, Cimini E, Colavita F, Bettini A, Tartaglia E, Sbarra S, Meschi S, Lapa D, Francalancia M, Bordi L, Mazzotta V, Coen S, Mizzoni K, Beccacece A, Nicastri E, Pierelli L, Antinori A, Girardi E, Vaia F, Sette A, Grifoni A, Goletti D, Puro V, Maggi F. Matusali G, et al. Vaccines (Basel). 2023 Sep 28;11(10):1541. doi: 10.3390/vaccines11101541. Vaccines (Basel). 2023. PMID: 37896943 Free PMC article. - The prospective outcome of the monkeypox outbreak in 2022 and characterization of monkeypox disease immunobiology.
Qudus MS, Cui X, Tian M, Afaq U, Sajid M, Qureshi S, Liu S, Ma J, Wang G, Faraz M, Sadia H, Wu K, Zhu C. Qudus MS, et al. Front Cell Infect Microbiol. 2023 Jul 18;13:1196699. doi: 10.3389/fcimb.2023.1196699. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37533932 Free PMC article. - T cells are ready for the fight against monkeypox.
Wellington D, Dong T. Wellington D, et al. Cell Host Microbe. 2022 Dec 14;30(12):1653-1654. doi: 10.1016/j.chom.2022.11.004. Cell Host Microbe. 2022. PMID: 36521439 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials